Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Nephrology · Anti-glomerular basement membrane disease

Understanding Your Diagnosis: Anti-GBM Disease

At a Glance

Anti-GBM disease is a rare autoimmune emergency in which antibodies attack the kidney filters and sometimes the lung air sacs. Rapid treatment with plasma exchange, corticosteroids, and immune-suppressing medicine aims to stop the attack and preserve kidney function.

If you are reading this, you have likely just experienced a whirlwind of medical events. Anti-GBM disease (also known as Goodpasture disease) often arrives as an acute medical crisis: you may have felt fine just weeks ago, and now you are in a hospital bed being told your kidneys—and perhaps your lungs—are under attack by your own immune system [1][2].

This diagnosis is overwhelming because of its speed and intensity. It is common for patients to require dialysis (a machine that filters waste from the blood) upon arriving at the hospital [2][3]. While this sudden change is terrifying, understanding what is happening inside your body can help you partner with your medical team during these critical first days.

An Exceptionally Rare Event

The first thing to understand is that Anti-GBM disease is incredibly rare. It affects only about 0.5 to 1 person out of every million people each year [4][5]. Because it is so uncommon, many doctors—even experienced ones—may have never treated a case before yours [4]. You are likely being cared for by a specialized team of nephrologists (kidney doctors) and perhaps pulmonologists (lung doctors) who are following specific, urgent protocols designed for this exact condition.

Why Your Body Is Attacking Itself

In a healthy body, your immune system produces antibodies to fight off invaders like viruses or bacteria. In Anti-GBM disease, the immune system makes a mistake. It produces autoantibodies—antibodies that target your own healthy tissue [6].

Specifically, these antibodies target a protein called Type IV collagen. This specific type of collagen is found in the basement membranes—specialized layers that line small blood vessels [6]. In Anti-GBM disease, these antibodies attack two main places in the body:

  • The Kidneys: The attack targets the tiny filters called glomeruli. When antibodies bind to these filters, they cause intense inflammation and “crescent-shaped” lesions that prevent the kidneys from cleaning your blood [7][8].
  • The Lungs: The attack targets the air sacs (alveoli) where oxygen enters your blood. If the antibodies attack here, it can cause bleeding in the lungs, which might make you cough up blood or feel very short of breath [9][10].

Roughly 40% to 60% of people with this condition experience both kidney and lung issues, though some experience only one or the other [9][11]. Doctors may ask if you have a history of smoking or exposure to certain fumes; this is just to gather clinical context, as these are known associations. It is important to remember that you did not cause this disease.

The Immediate Response

Because the damage can happen quickly, your care team will quickly evaluate you for a “triple therapy” approach to stop the attack. This approach is highly individualized based on your age, overall health, lung involvement, and how much permanent damage is already present in your kidneys.

  1. Plasma Exchange (Plasmapheresis): This is a process where your blood is cycled through a machine that physically removes the harmful antibodies from your bloodstream [12][13].
  2. Corticosteroids: High doses of intravenous steroids are used to rapidly dial down the active inflammation in your kidneys and lungs [12][11].
  3. Immunosuppression: Medications like cyclophosphamide or rituximab are given to stop your immune system from making new harmful antibodies [12].

Navigating the Early Days

The sudden shift from being a healthy person to a patient requiring intensive care is a profound emotional shock. It is normal to feel a sense of “medical whiplash.” In many cases, the goal of treatment is to stabilize the body and preserve as much kidney function as possible [14][2].

Your doctors may perform a kidney biopsy—taking a tiny sample of kidney tissue—to see exactly how much active inflammation versus permanent scarring is present. This helps them determine how aggressive the treatment should be and what the chances are for your kidneys to recover their function over time [11][10]. While the path forward involves many challenges, working closely with specialists to quickly start the right treatment is the most important step in controlling the disease [14][12]. Do not hesitate to involve hospital social workers or mental health professionals to help you and your family navigate the logistics and emotional toll of this diagnosis.

Common questions in this guide

What is Anti-GBM disease, and why does it affect the kidneys and lungs?
Anti-GBM disease is a rare autoimmune illness in which the body makes antibodies against type IV collagen in basement membranes. These antibodies can inflame the kidney filters and, in some people, the lung air sacs, causing kidney problems or bleeding in the lungs.
Is Anti-GBM disease the same as Goodpasture disease?
Goodpasture disease is another name used for Anti-GBM disease. The condition can involve the kidneys, the lungs, or both, so symptoms and treatment needs may differ from person to person.
Why might someone with Anti-GBM disease need dialysis?
Inflammation can damage the kidney filters so they cannot remove enough waste and extra fluid from the blood. Dialysis performs that filtering work while doctors treat the immune attack, and it may be needed temporarily or longer term depending on kidney damage and recovery.
What is the three-part treatment for Anti-GBM disease?
Treatment often combines plasma exchange to remove harmful antibodies, high-dose corticosteroids to reduce inflammation, and an immune-suppressing medicine such as cyclophosphamide or rituximab to limit production of new antibodies. Doctors adjust this approach based on kidney and lung involvement, overall health, age, and existing kidney damage.
What can a kidney biopsy tell me about Anti-GBM disease?
A kidney biopsy shows how much active inflammation and permanent scarring are present. Those findings help the medical team judge how intensive treatment should be and estimate how much kidney function might recover.
What symptoms can Anti-GBM disease cause?
Kidney involvement may cause fatigue and tea-colored urine, while lung involvement can cause cough, coughing up blood, or shortness of breath. Some people have kidney and lung problems together, but others have only one affected organ.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many cases of Anti-GBM disease has this hospital or my medical team treated in the last year?
  2. 2.Based on my biopsy results and overall health, how are we balancing the need for aggressive treatment with the risk of severe infections?
  3. 3.Am I 'double-positive' for both Anti-GBM and ANCA antibodies, and how would that change my long-term treatment plan?
  4. 4.What is the specific goal of the plasma exchange sessions I am receiving, and how is the schedule being determined for my case?
  5. 5.What precautions, such as specific vaccinations or prophylactic antibiotics, are we taking to prevent infections while I am on high-dose immunosuppressants?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Clinical Profile and Renal Survival of Anti-Glomerular Basement Membrane Disease Patients: A Retrospective Case Series from Northern India.

    Kumar A, Gupta S, Jarial KDS, et al.

    Glomerular diseases 2023; (3(1)):241-247 doi:10.1159/000534498.

    PMID: 38021463
  2. 2

    Anti-glomerular basement membrane disease: A contemporary case series from a large university hospital center.

    Catarina Oliveira A, Figueiredo R, Correia R, et al.

    Nefrologia 2026; (46(7)):501522 doi:10.1016/j.nefroe.2026.501522.

    PMID: 42618193
  3. 3

    Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.

    Alchi B, Griffiths M, Sivalingam M, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015; (30(5)):814-21 doi:10.1093/ndt/gfu399.

    PMID: 25609740
  4. 4

    Anti-Glomerular Basement Membrane Disease in a 10-year-old Child: A Case Report.

    Anjum MF, Twanabasu S, Shrestha S, et al.

    JNMA; journal of the Nepal Medical Association 2023; (61(262)):552-554 doi:10.31729/jnma.8193.

    PMID: 37464846
  5. 5

    Atypical Anti-Glomerular Basement Membrane Disease With Diffuse Crescentic Membranoproliferative Glomerulonephritis: Case Report and Review of Literature.

    Elshirbeny M, Alkadi MM, Mujeeb I, Fituri O

    Qatar medical journal 2020; (2020(1)):16 doi:10.5339/qmj.2020.16.

    PMID: 32391252
  6. 6

    Autoimmunity in Anti-Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy.

    Kuang H, Liu J, Jia XY, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(1)):90-99 doi:10.1053/j.ajkd.2022.07.006.

    PMID: 36334986
  7. 7

    Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.

    Tang A, Zhao X, Tao T, et al.

    Frontiers in immunology 2023; (14()):1229806 doi:10.3389/fimmu.2023.1229806.

    PMID: 37781380
  8. 8

    Antiglomerular Basement Membrane Disease.

    McAdoo SP, Pusey CD

    Seminars in respiratory and critical care medicine 2018; (39(4)):494-503 doi:10.1055/s-0038-1669413.

    PMID: 30404116
  9. 9

    Goodpasture syndrome and anti-glomerular basement membrane disease.

    Reggiani F, L'Imperio V, Calatroni M, et al.

    Clinical and experimental rheumatology 2023; (41(4)):964-974 doi:10.55563/clinexprheumatol/tep3k5.

    PMID: 36995324
  10. 10

    Anti-Glomerular Basement Membrane Disease: Recent Updates.

    Bharati J, Jhaveri KD, Salama AD, Oni L

    Advances in kidney disease and health 2024; (31(3)):206-215 doi:10.1053/j.akdh.2024.04.007.

    PMID: 39004460
  11. 11

    Anti-glomerular basement membrane disease-treatment standard.

    McAdoo SP, Pusey CD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025; (41(1)):42-54 doi:10.1093/ndt/gfaf190.

    PMID: 40973182
  12. 12

    Outcome of rituximab treatment in children with non-dialysis-dependent anti-GBM disease.

    Klaus R, Kanzelmeyer N, Haffner D, Lange-Sperandio B

    Pediatric nephrology (Berlin, Germany) 2025; (40(2)):423-430 doi:10.1007/s00467-024-06512-4.

    PMID: 39320552
  13. 13

    Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti-glomerular basement membrane disease.

    Jacobs JW, Figueroa Villalba CA, Stendahl K, et al.

    Journal of clinical apheresis 2023; (38(6)):770-777 doi:10.1002/jca.22088.

    PMID: 37698143
  14. 14

    Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients.

    Liu Y, Wu Y, Wei W, et al.

    Renal failure 2024; (46(2)):2400539 doi:10.1080/0886022X.2024.2400539.

    PMID: 39258391

This page provides general information about the urgent evaluation and treatment of Anti-GBM disease for informational purposes only and does not constitute medical advice. Your nephrologist and other treating specialists should guide decisions about your specific condition.

Get notified when new evidence is published on anti-basement membrane glomerulonephritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.